Document is current
Any future updates will be listed below
-
Authors
Cleto, Sara
Haslinger, Kristina
Prather, Kristala L. J.
Lu, Timothy K. http://orcid.org/0000-0002-3918-8923
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH Director's New Innovator Award 1-DP2-OD008435-01)
Novartis Pharmaceuticals Corporation (Novartis Award 68148476)
Defense Threat Reduction Agency (United States Defense Threat Reduction Agency HDTRA1-14-1-0007, United States Defense Threat Reduction Agency HDTRA1-15-1-0050)
Office of Naval Research (4500000552)
Human Frontier Science Program (LT000969/2016-L)
- License Information
-
More Information
Article History
Received: 14 October 2020
Accepted: 31 January 2021
First Online: 15 March 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: T.K.L. is a co-founder of Senti Biosciences, Synlogic, Engine Biosciences, Tango Therapeutics, Corvium, BiomX, and Eligo Biosciences. T.K.L. also holds financial interests in nest.bio, Ampliphi, IndieBio, MedicusTek, Quark Biosciences, and Personal Genomics. None of the companies listed have competing interests with the science in this manuscript.
